Skip to main content

Peer Review reports

From: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion

Original Submission
22 Jan 2021 Submitted Original manuscript
13 Jul 2021 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
15 Jul 2021 Editorially accepted
19 Aug 2021 Article published 10.1186/s13063-021-05461-9

You can find further information about peer review here.

Back to article page